Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michaela Liedtke

Showing results (21-30 of 110) with videos related to

Pageof 11
Sort By:
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|November 5, 2011
Heart transplantation and cardiac amyloidosis: approach to screening and novel management strategiesBrandon C Varr, Michaela Liedtke, Sally Arai, et al.
Blood|June 16, 2017
Daratumumab yields rapid and deep hematologic responses in patients with heavily pretreated AL amyloidosisGregory P Kaufman, Stanley L Schrier, Richard A Lafayette, et al.
Haematologica|May 30, 2013
Lenalidomide, melphalan and dexamethasone in a population of patients with immunoglobulin light chain amyloidosis with high rates of advanced cardiac involvementShira Dinner, Wesley Witteles, Anosheh Afghahi, et al.
Leukemia Research|December 3, 2014
Salvage therapy with mitoxantrone, etoposide and cytarabine in relapsed or refractory acute lymphoblastic leukemiaMichaela Liedtke, Tamara Dunn, Shira Dinner, et al.
The American Journal of Cardiology|August 29, 2017
Functional Cardiac Recovery and Hematologic Response to Chemotherapy in Patients With Light-Chain Amyloidosis (from the Stanford University Amyloidosis Registry)Mirela Tuzovic, Yukari Kobayashi, Matthew Wheeler, et al.
The American Journal of Surgical Pathology|March 13, 2014
Indolent T-lymphoblastic proliferation with disseminated multinodal involvement and partial CD33 expressionRobert S Ohgami, Anoop K Sendamarai, Susan K Atwater, et al.
Journal of Adolescent and Young Adult Oncology|August 24, 2023
Implementation of a Pilot Clinic for Pediatric to Adult Cancer Survivorship TransitionsAlexander Hai Jin, Pamela J Simon, Alison Clayton, et al.
British Journal of Haematology|February 26, 2013
The prognostic value of diagnosing concurrent multiple myeloma in immunoglobulin light chain amyloidosisShira Dinner, Wesley Witteles, Ronald Witteles, et al.
British Journal of Haematology|April 5, 2016
A phase 1, open-label, dose-escalation study of pralatrexate in combination with bortezomib in patients with relapsed/refractory multiple myelomaTamara J Dunn, Shira Dinner, Elizabeth Price, et al.
Blood Advances|March 10, 2020
Single-cell mutational profiling enhances the clinical evaluation of AML MRDAsiri Ediriwickrema, Alexey Aleshin, Johannes G Reiter, et al.
Pageof 11

Showing results (21-30 of 110) with videos related to

Sort By:
Pageof 11
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|November 5, 2011
Heart transplantation and cardiac amyloidosis: approach to screening and novel management strategiesBrandon C Varr, Michaela Liedtke, Sally Arai, et al.
Blood|June 16, 2017
Daratumumab yields rapid and deep hematologic responses in patients with heavily pretreated AL amyloidosisGregory P Kaufman, Stanley L Schrier, Richard A Lafayette, et al.
Haematologica|May 30, 2013
Lenalidomide, melphalan and dexamethasone in a population of patients with immunoglobulin light chain amyloidosis with high rates of advanced cardiac involvementShira Dinner, Wesley Witteles, Anosheh Afghahi, et al.
Leukemia Research|December 3, 2014
Salvage therapy with mitoxantrone, etoposide and cytarabine in relapsed or refractory acute lymphoblastic leukemiaMichaela Liedtke, Tamara Dunn, Shira Dinner, et al.
The American Journal of Cardiology|August 29, 2017
Functional Cardiac Recovery and Hematologic Response to Chemotherapy in Patients With Light-Chain Amyloidosis (from the Stanford University Amyloidosis Registry)Mirela Tuzovic, Yukari Kobayashi, Matthew Wheeler, et al.
The American Journal of Surgical Pathology|March 13, 2014
Indolent T-lymphoblastic proliferation with disseminated multinodal involvement and partial CD33 expressionRobert S Ohgami, Anoop K Sendamarai, Susan K Atwater, et al.
Journal of Adolescent and Young Adult Oncology|August 24, 2023
Implementation of a Pilot Clinic for Pediatric to Adult Cancer Survivorship TransitionsAlexander Hai Jin, Pamela J Simon, Alison Clayton, et al.
British Journal of Haematology|February 26, 2013
The prognostic value of diagnosing concurrent multiple myeloma in immunoglobulin light chain amyloidosisShira Dinner, Wesley Witteles, Ronald Witteles, et al.
British Journal of Haematology|April 5, 2016
A phase 1, open-label, dose-escalation study of pralatrexate in combination with bortezomib in patients with relapsed/refractory multiple myelomaTamara J Dunn, Shira Dinner, Elizabeth Price, et al.
Blood Advances|March 10, 2020
Single-cell mutational profiling enhances the clinical evaluation of AML MRDAsiri Ediriwickrema, Alexey Aleshin, Johannes G Reiter, et al.
Pageof 11